Article Versions Notes

Lalos A, Neri O, Ercan C, Wilhelm A, Staubli S, Posabella A, Weixler B, Terracciano L, Piscuoglio S, Stadlmann S, et al. High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival. Cancers. 2021; 13(22):5783. https://doi.org/10.3390/cancers13225783

Lalos, Alexandros, Ornella Neri, Caner Ercan, Alexander Wilhelm, Sebastian Staubli, Alberto Posabella, Benjamin Weixler, Luigi Terracciano, Salvatore Piscuoglio, Sylvia Stadlmann, and et al. 2021. "High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival" Cancers 13, no. 22: 5783. https://doi.org/10.3390/cancers13225783

Lalos, A., Neri, O., Ercan, C., Wilhelm, A., Staubli, S., Posabella, A., Weixler, B., Terracciano, L., Piscuoglio, S., Stadlmann, S., Spagnoli, G. C., Droeser, R. A., & Singer, G. (2021). High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival. Cancers, 13(22), 5783. https://doi.org/10.3390/cancers13225783